Pregnancy outcome after use of cranberry in pregnancy - the Norwegian mother and child cohort study

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Heitmann, Kristine ^a,b   Nordeng, Hedvig ^c,d   Holst, Lone ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b University of Oslo ^*  (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Norwegian Institute of Public Heal   (Norway)

Author keywords

Antibiotics; Congenital malformations; Cranberry; Herbal medicine; Pregnancy; Pregnancy outcome; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; APGAR SCORE; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CRANBERRY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOSPADIAS; LOW BIRTH WEIGHT; MACROCEPHALY; MAJOR CLINICAL STUDY; NEWBORN DEATH; NEWBORN INFECTION; PATIENT SAFETY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; QUESTIONNAIRE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; STILLBIRTH; THIRD TRIMESTER PREGNANCY; URINARY TRACT INFECTION; VAGINA BLEEDING;

ADULT; BEVERAGES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONGENITAL ABNORMALITIES; FEMALE; FRUIT; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; NORWAY; PLANT PREPARATIONS; PREGNANCY; PREGNANCY OUTCOME; QUESTIONNAIRES; REGRESSION ANALYSIS; STILLBIRTH; VACCINIUM MACROCARPON;

EID: 84889019977     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-345     Document Type: Article

References (59)

1. Blumenthal M. The ABC Clinical Guide to Herbs 2003, New York: American Botanical Council/Thieme.
2. United States Pharmacopeial Convention Cranberry liquid preparation. United States Pharmacopeia (USP 36) - The National Formulary (NF 31) 2013, Rockville, MD: United States Pharmacopeial Convention, Inc, United States Pharmacopeial Convention.
3. Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth 2006, 6:21. 10.1186/1471-2393-6-21, 1544352, 16780602.
4. Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003, 188(4):1039-1045. 10.1067/mob.2003.223, 12712107.
5. Glover DD, Rybeck BF, Tracy TS. Medication use in a rural gynecologic population: prescription, over-the-counter, and herbal medicines. Am J Obstet Gynecol 2004, 190(2):351-357. 10.1016/j.ajog.2003.08.033, 14981373.
6. Holst L, Wright D, Haavik S, Nordeng H. The use and the user of herbal remedies during pregnancy. J Altern Complement Med 2009, 15(7):787-792. 10.1089/acm.2008.0467, 19538045.
7. Nordeng H, Bayne K, Havnen GC, Paulsen BS. Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome. Complement Ther Clin Pract 2011, 17(3):147-151. 10.1016/j.ctcp.2010.09.002, 21742280.
8. Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest 2008, 38(SUPPL.2):50-57.
9. Mittal P, Wing DA. Urinary tract infections in pregnancy. Clin Perinatol 2005, 32(3):749-764. 10.1016/j.clp.2005.05.006, 16085031.
10. MacLean AB. Urinary tract infection in pregnancy. Int J Antimicrob Agents 2001, 17(4):273-276. discussion 276-277, 10.1016/S0924-8579(00)00354-X, 11295407.
11. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989, 73(4):576-582.
12. Schieve LA, Handler A, Hershow R, Persky V, Davis F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Publ Health 1994, 84(3):405-410.
13. Farkash E, Weintraub A, Sergienko R, Wiznitzer A, Zlotnik A, Sheiner E. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol 2012, 162(1):24-27. 10.1016/j.ejogrb.2012.01.024, 22381037.
14. Mazor-Dray E, Levy A, Sheiner E. Maternal urinary tract infection: is it an independent risk factor for adverse pregnancy outcomes?. Am J Obstet Gynecol 2008, 199(6):S150.
15. Jolley JA, Wing DA. Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs 2010, 70(13):1643-1655. 10.2165/11538050-000000000-00000, 20731473.
16. Berard A, Santos F, Ferreira E, Perreault S. Urinary tract infections during pregnancy. Urinary tract infections 2011, Rijeka: InTech, Peter T.
17. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007, 2:CD000490.
18. Nicolle L, Bradley S, Colgan R, Rice J, Schaeffer A, Hooton T. Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005, 40(5):643-654. 10.1086/427507, 15714408.
19. National Collaborating Centre for Women's and Children's Health Antenatal care: routine care for the healthy pregnant woman 2008, London: RCOG Press, 2, http://www.nice.org.uk/nicemedia/pdf/CG62FullGuidelineCorrectedJune2008July2009.pdf. Accessed 06 November 2013, National Collaborating Centre for Women's and Children's Health.
20. Natural medicines comprehensive database Cranberry monograph http://naturaldatabase.therapeuticresearch.com/home.aspx?cs=&s=ND. Accessed 06 November 2013, Natural medicines comprehensive database.
21. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989, 33(1):92-98. 10.1128/AAC.33.1.92, 171427, 2653218.
22. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 2010, 10:94. 10.1186/1471-2334-10-94, 2873556, 20398248.
23. Foo LY, Lu Y, Howell AB, Vorsa N. A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 2000, 63(9):1225-1228. 10.1021/np000128u, 11000024.
24. Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: what is the evidence?. Urology 2001, 57(3):407-413. 10.1016/S0090-4295(00)01100-6, 11248607.
25. Jepson RG, Mihaljevic L, Craig J. Cranberries for treating urinary tract infections. Cochrane Database Syst Rev 2000, 2:CD001322.
26. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008, 1:CD001321.
27. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012, 10:CD001321.
28. Wing DA, Rumney PJ, Preslicka CW, Chung JH. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol 2008, 180(4):1367-1372. 10.1016/j.juro.2008.06.016, 2631561, 18707726.
29. Hess HM, Miller RK. Herbs during pregnancy. Drugs During Pregnancy and Lactation 2007, 485-501. London: Elsevier, Schaefer C, Peters P, Miller R, 2.
30. Mills E, Dugoua JJ, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. An evidence-Based Approach 2006, Taylor&Francis Group: London and New York.
31. Barnes J, Anderson L, Phillipson J. Herbal Medicines 2007, London: Pharmaceutical Press, 3.
32. Hamann G, Campbell J, George C. Warfarin-cranberry juice interaction. Ann Pharmacother 2011, 45(3):e17. 10.1345/aph.1P451, 21364039.
33. Abdul MIM, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, McLachlan AJ. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Brit J Pharmacol 2008, 154(8):1691-1700.
34. Zikria J, Goldman R, Ansell J. Cranberry juice and warfarin: when bad publicity trumps science. Am J Med 2010, 123(5):384-392. 10.1016/j.amjmed.2009.08.019, 20399311.
35. Norwegian Institue of Public Health What is the Norwegian Mother and Child Cohort Study? http://www.fhi.no/artikler/?id=65519. Accessed 06 November 2013, Norwegian Institue of Public Health.
36. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C. Cohort profile: the Norwegian mother and child cohort study (MoBa). Int J Epidemiol 2006, 35(5):1146-1150. 10.1093/ije/dyl170, 16926217.
37. Norwegian Institue of Public Health The Nowegian Mother and Child Cohort Study. Questionnaire 1 http://www.fhi.no/dokumenter/1f32a49514.pdf. Accessed 06 November 2013, Norwegian Institue of Public Health.
38. Norwegian Institue of Public Health The Nowegian Mother and Child Cohort Study. Questionnaire 3 http://www.fhi.no/dokumenter/7b6b32b0cd.pdf. Accessed 06 November 2013, Norwegian Institue of Public Health.
39. Norwegian Institue of Public Health The Nowegian Mother and Child Cohort Study. Questionnaire 4 http://www.fhi.no/dokumenter/9ecca1c459.pdf. Accessed 06 November 2013, Norwegian Institue of Public Health.
40. Irgens LM. The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000, 79(6):435-439. 10.1080/j.1600-0412.2000.079006435.x, 10857866.
41. Norwegian Institue of Public Health Medical Birth Registry of Norway http://www.fhi.no/artikler/?id=94819]. Accessed 06 November 2013, Norwegian Institue of Public Health.
42. World Health Organization International statistical classification of disease and related health problems, 10th revision http://apps.who.int/classifications/icd10/browse/2010/en. Accessed 06 November 2013, World Health Organization.
43. Norwegian Institue of Public Health Definisjonsrapporter for variabler i Medisinsk fødselsregister (in Norwegian). English: Definition report for variables in the Medical Birth Registry of Norway http://www.fhi.no/dokumenter/8105c63e8e.pdf. Accessed 06 November 2013, Norwegian Institue of Public Health.
44. Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006, 26(9):1314-1319. 10.1592/phco.26.9.1314, 16945054.
45. Duthie GG, Kyle JAM, Jenkinson AM, Duthie SJ, Baxter GJ, Paterson JR. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem 2005, 53(8):2897-2900. 10.1021/jf040393b, 15826036.
46. Rosenkranz B, Fischer C, Meese CO, Frolich JC. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol 1986, 21(3):309-317. 10.1111/j.1365-2125.1986.tb05195.x, 1400854, 3083851.
47. Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, Sorokin Y. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol 2005, 22(6):321-324. 10.1055/s-2005-873235, 16118721.
48. Facchinetti F, Pedrielli G, Benoni G, Joppi M, Verlato G, Dante G, Balduzzi S, Cuzzolin L. Herbal supplements in pregnancy: unexpected results from a multicentre study. Hum Reprod 2012, 27(11):3161-3167. 10.1093/humrep/des303, 22926840.
49. Moussally K, Oraichi D, Berard A. Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf 2009, 18(6):454-461. 10.1002/pds.1731, 19326360.
50. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280(18):1569-1575. 10.1001/jama.280.18.1569, 9820257.
51. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alternative Ther Health Med 2005, 11(1):42-49.
52. Hanssen B, Grimsgaard S, Launso L, Fonnebo V, Falkenberg T, Rasmussen NK. Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care 2005, 23(1):57-62. 10.1080/02813430510018419, 16025876.
53. Van Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, De Jong-Van Den Berg LTW. Questions about drugs: How do pregnant women solve them?. Pharm World Sci 1994, 16(6):254-259.
54. Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol 2010, 66(2):207-214. 10.1007/s00228-009-0744-2, 19841915.
55. Duff P. Pyelonephritis in pregnancy. Clin Obstet Gynecol 1984, 27(1):17-31. 10.1097/00003081-198403000-00006, 6368078.
56. McCormick T, Ashe RG, Kearney PM. Urinary tract infection in pregnancy. Obstet Gynaecol 2008, 10(3):156-162.
57. Melve KK, Lie RT, Skjaerven R, Van Der Hagen CB, Gradek GA, Jonsrud C, Braathen GJ, Irgens LM. Registration of Down syndrome in the medical birth registry of Norway: validity and time trends. Acta Obstet Gynecol Scand 2008, 87(8):824-830. 10.1080/00016340802217184, 18607831.
58. Kubon C, Sivertsen A, Vindenes HA, Abyholm F, Wilcox A, Lie RT. Completeness of registration of oral clefts in a medical birth registry: a population-based study. Acta Obstet Gynecol Scand 2007, 86(12):1453-1457. 10.1080/08037050701645090, 17851803.
59. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P. Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 2009, 23(6):597-608. 10.1111/j.1365-3016.2009.01062.x, 19840297.